Clinical trial Recruiting at 1 site Observational

Understanding the genetic causes of skeletal diseases

Official title: Decoding the Genetic Landscape of Skeletal Diseases

Run by Karolinska Institutet · NCT05876416 · Data updated 2026-11-12

This study is trying to find the genetic causes of congenital skeletal disorders to help improve diagnosis and treatment for people affected by these conditions.

Quick facts

Study typeObservational
SexAll
Enrollment450 (estimated)
SponsorKarolinska Institutet
Academic / other
Locations1 site (Stockholm)
StatusRecruiting
StartedJanuary 1, 2015
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedMay 25, 2023
Trial IDNCT05876416 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with clinically suspected skeletal dysplasia, abnormal height, and radiographic abnormalities.

Probably not a fit

Patients with no available radiographic data or those with suspected environmental or multifactorial causes may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to identify genetic causes of congenital skeletal disorders that remain unsolved. It utilizes whole genome sequencing and RNA sequencing to analyze DNA samples from participants with genetic skeletal disorders. The study also investigates the effects of newly identified genetic variants in cellular models and transgenic mice. Additionally, it compiles data on the natural progression and complications associated with different groups of skeletal disorders. The collaboration involves multiple prestigious institutions to enhance diagnostic capabilities and treatment strategies for affected patients.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnostics and personalized treatment strategies for patients with genetic skeletal disorders.

How similar studies have gone: Other studies have shown success in identifying genetic causes of rare diseases using similar genomic approaches, indicating a promising avenue for this research.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Clinically suspected skeletal dysplasia based on previous investigations

Abnormal height

Radiographic abnormalities of the skeleton in addition to other syndromic features

Healthy relatives of the affected study participants

Exclusion Criteria:

No radiographic data available from clinical investigations

Suspected environmental or multifactorial causes

Where it's running

  • Karolinska University Hospital
    Stockholm, Sweden
    Recruiting

Study contacts

  • Principal investigator: Giedre Grigelioniene, MD, — Dept Molecular Medicine and Surgery, KI
  • Study coordinator: Giedre Grigelioniene, MD, PhD
  • Email: giedre.grigelioniene@ki.se
  • Phone: +46706287697

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.